aluates Reports

$ 0.0

Automative

Global Metastatic Prostate Cancer Treatment Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-17J8631

Global Metastatic Prostate Cancer Treatment Market Insights Forecast to 2028

BUY CHAPTERS

Global Metastatic Prostate Cancer Treatment Market Research Report 2025

Code: QYRE-Auto-17J8631

Report

July 2025

Pages:83

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AB Science

BeiGene Ltd

eFFECTOR Therapeutics

Immunomedics(Gilead Sciences, Inc.)

Myovant Biosciences

SeleXel

Zenith Epigenetics Ltd.

Vasgene Therapeutics Inc

Telix Pharmaceuticals

Arvinas Inc

Amgen Inc

Genentech Inc

Metastatic Prostate Cancer Treatment Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Metastatic Prostate Cancer Treatment Market

The global market for Metastatic Prostate Cancer Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Metastatic prostate cancer is a type of prostate cancer which spreads to the other parts of body such as bones or lymph nodes.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Metastatic Prostate Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metastatic Prostate Cancer Treatment.

The Metastatic Prostate Cancer Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Metastatic Prostate Cancer Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Metastatic Prostate Cancer Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Metastatic Prostate Cancer Treatment Market Report

Report Metric	Details
Report Name	Metastatic Prostate Cancer Treatment Market
CAGR	5%
Segment by Type	Mono Combination Mono/Combination
Segment by Application	Hospital Drug Store Online Pharmacy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AB Science, BeiGene, eFFECTOR Therapeutics, Immunomedics(Gilead Sciences, Inc.), Myovant Biosciences, SeleXel, Zenith Epigenetics Ltd., VasGene Therapeutics, Inc., Telix Pharmaceuticals, Arvinas Inc., Amgen, Genentech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Metastatic Prostate Cancer Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Metastatic Prostate Cancer Treatment Market report?

Ans: The main players in the Metastatic Prostate Cancer Treatment Market are AB Science, BeiGene, eFFECTOR Therapeutics, Immunomedics(Gilead Sciences, Inc.), Myovant Biosciences, SeleXel, Zenith Epigenetics Ltd., VasGene Therapeutics, Inc., Telix Pharmaceuticals, Arvinas Inc., Amgen, Genentech

What are the Application segmentation covered in the Metastatic Prostate Cancer Treatment Market report?

Ans: The Applications covered in the Metastatic Prostate Cancer Treatment Market report are Hospital, Drug Store, Online Pharmacy

What are the Type segmentation covered in the Metastatic Prostate Cancer Treatment Market report?

Ans: The Types covered in the Metastatic Prostate Cancer Treatment Market report are Mono, Combination, Mono/Combination

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Metastatic Prostate Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Mono

1.2.3 Combination

1.2.4 Mono/Combination

1.3 Market by Application

1.3.1 Global Metastatic Prostate Cancer Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Drug Store

1.3.4 Online Pharmacy

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Metastatic Prostate Cancer Treatment Market Perspective (2020-2031)

2.2 Global Metastatic Prostate Cancer Treatment Growth Trends by Region

2.2.1 Global Metastatic Prostate Cancer Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Metastatic Prostate Cancer Treatment Historic Market Size by Region (2020-2025)

2.2.3 Metastatic Prostate Cancer Treatment Forecasted Market Size by Region (2026-2031)

2.3 Metastatic Prostate Cancer Treatment Market Dynamics

2.3.1 Metastatic Prostate Cancer Treatment Industry Trends

2.3.2 Metastatic Prostate Cancer Treatment Market Drivers

2.3.3 Metastatic Prostate Cancer Treatment Market Challenges

2.3.4 Metastatic Prostate Cancer Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Metastatic Prostate Cancer Treatment Players by Revenue

3.1.1 Global Top Metastatic Prostate Cancer Treatment Players by Revenue (2020-2025)

3.1.2 Global Metastatic Prostate Cancer Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Metastatic Prostate Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Metastatic Prostate Cancer Treatment Revenue

3.4 Global Metastatic Prostate Cancer Treatment Market Concentration Ratio

3.4.1 Global Metastatic Prostate Cancer Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Metastatic Prostate Cancer Treatment Revenue in 2024

3.5 Global Key Players of Metastatic Prostate Cancer Treatment Head office and Area Served

3.6 Global Key Players of Metastatic Prostate Cancer Treatment, Product and Application

3.7 Global Key Players of Metastatic Prostate Cancer Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Metastatic Prostate Cancer Treatment Breakdown Data by Type

4.1 Global Metastatic Prostate Cancer Treatment Historic Market Size by Type (2020-2025)

4.2 Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Type (2026-2031)

5 Metastatic Prostate Cancer Treatment Breakdown Data by Application

5.1 Global Metastatic Prostate Cancer Treatment Historic Market Size by Application (2020-2025)

5.2 Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Metastatic Prostate Cancer Treatment Market Size (2020-2031)

6.2 North America Metastatic Prostate Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Metastatic Prostate Cancer Treatment Market Size by Country (2020-2025)

6.4 North America Metastatic Prostate Cancer Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Metastatic Prostate Cancer Treatment Market Size (2020-2031)

7.2 Europe Metastatic Prostate Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Metastatic Prostate Cancer Treatment Market Size by Country (2020-2025)

7.4 Europe Metastatic Prostate Cancer Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size (2020-2031)

8.2 Asia-Pacific Metastatic Prostate Cancer Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Metastatic Prostate Cancer Treatment Market Size (2020-2031)

9.2 Latin America Metastatic Prostate Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Metastatic Prostate Cancer Treatment Market Size by Country (2020-2025)

9.4 Latin America Metastatic Prostate Cancer Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size (2020-2031)

10.2 Middle East & Africa Metastatic Prostate Cancer Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AB Science

11.1.1 AB Science Company Details

11.1.2 AB Science Business Overview

11.1.3 AB Science Metastatic Prostate Cancer Treatment Introduction

11.1.4 AB Science Revenue in Metastatic Prostate Cancer Treatment Business (2020-2025)

11.1.5 AB Science Recent Development

11.2 BeiGene

11.2.1 BeiGene Company Details

11.2.2 BeiGene Business Overview

11.2.3 BeiGene Metastatic Prostate Cancer Treatment Introduction

11.2.4 BeiGene Revenue in Metastatic Prostate Cancer Treatment Business (2020-2025)

11.2.5 BeiGene Recent Development

11.3 eFFECTOR Therapeutics

11.3.1 eFFECTOR Therapeutics Company Details

11.3.2 eFFECTOR Therapeutics Business Overview

11.3.3 eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Introduction

11.3.4 eFFECTOR Therapeutics Revenue in Metastatic Prostate Cancer Treatment Business (2020-2025)

11.3.5 eFFECTOR Therapeutics Recent Development

11.4 Immunomedics(Gilead Sciences, Inc.)

11.4.1 Immunomedics(Gilead Sciences, Inc.) Company Details

11.4.2 Immunomedics(Gilead Sciences, Inc.) Business Overview

11.4.3 Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Cancer Treatment Introduction

11.4.4 Immunomedics(Gilead Sciences, Inc.) Revenue in Metastatic Prostate Cancer Treatment Business (2020-2025)

11.4.5 Immunomedics(Gilead Sciences, Inc.) Recent Development

11.5 Myovant Biosciences

11.5.1 Myovant Biosciences Company Details

11.5.2 Myovant Biosciences Business Overview

11.5.3 Myovant Biosciences Metastatic Prostate Cancer Treatment Introduction

11.5.4 Myovant Biosciences Revenue in Metastatic Prostate Cancer Treatment Business (2020-2025)

11.5.5 Myovant Biosciences Recent Development

11.6 SeleXel

11.6.1 SeleXel Company Details

11.6.2 SeleXel Business Overview

11.6.3 SeleXel Metastatic Prostate Cancer Treatment Introduction

11.6.4 SeleXel Revenue in Metastatic Prostate Cancer Treatment Business (2020-2025)

11.6.5 SeleXel Recent Development

11.7 Zenith Epigenetics Ltd.

11.7.1 Zenith Epigenetics Ltd. Company Details

11.7.2 Zenith Epigenetics Ltd. Business Overview

11.7.3 Zenith Epigenetics Ltd. Metastatic Prostate Cancer Treatment Introduction

11.7.4 Zenith Epigenetics Ltd. Revenue in Metastatic Prostate Cancer Treatment Business (2020-2025)

11.7.5 Zenith Epigenetics Ltd. Recent Development

11.8 VasGene Therapeutics, Inc.

11.8.1 VasGene Therapeutics, Inc. Company Details

11.8.2 VasGene Therapeutics, Inc. Business Overview

11.8.3 VasGene Therapeutics, Inc. Metastatic Prostate Cancer Treatment Introduction

11.8.4 VasGene Therapeutics, Inc. Revenue in Metastatic Prostate Cancer Treatment Business (2020-2025)

11.8.5 VasGene Therapeutics, Inc. Recent Development

11.9 Telix Pharmaceuticals

11.9.1 Telix Pharmaceuticals Company Details

11.9.2 Telix Pharmaceuticals Business Overview

11.9.3 Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Introduction

11.9.4 Telix Pharmaceuticals Revenue in Metastatic Prostate Cancer Treatment Business (2020-2025)

11.9.5 Telix Pharmaceuticals Recent Development

11.10 Arvinas Inc.

11.10.1 Arvinas Inc. Company Details

11.10.2 Arvinas Inc. Business Overview

11.10.3 Arvinas Inc. Metastatic Prostate Cancer Treatment Introduction

11.10.4 Arvinas Inc. Revenue in Metastatic Prostate Cancer Treatment Business (2020-2025)

11.10.5 Arvinas Inc. Recent Development

11.11 Amgen

11.11.1 Amgen Company Details

11.11.2 Amgen Business Overview

11.11.3 Amgen Metastatic Prostate Cancer Treatment Introduction

11.11.4 Amgen Revenue in Metastatic Prostate Cancer Treatment Business (2020-2025)

11.11.5 Amgen Recent Development

11.12 Genentech

11.12.1 Genentech Company Details

11.12.2 Genentech Business Overview

11.12.3 Genentech Metastatic Prostate Cancer Treatment Introduction

11.12.4 Genentech Revenue in Metastatic Prostate Cancer Treatment Business (2020-2025)

11.12.5 Genentech Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

AB Science

BeiGene Ltd

eFFECTOR Therapeutics

Immunomedics(Gilead Sciences, Inc.)

Myovant Biosciences

SeleXel

Zenith Epigenetics Ltd.

Vasgene Therapeutics Inc

Telix Pharmaceuticals

Arvinas Inc

Amgen Inc

Genentech Inc

List of Tables

Table 1. Global Metastatic Prostate Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Mono

Table 3. Key Players of Combination

Table 4. Key Players of Mono/Combination

Table 5. Global Metastatic Prostate Cancer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Metastatic Prostate Cancer Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Metastatic Prostate Cancer Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Metastatic Prostate Cancer Treatment Market Share by Region (2020-2025)

Table 9. Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Metastatic Prostate Cancer Treatment Market Share by Region (2026-2031)

Table 11. Metastatic Prostate Cancer Treatment Market Trends

Table 12. Metastatic Prostate Cancer Treatment Market Drivers

Table 13. Metastatic Prostate Cancer Treatment Market Challenges

Table 14. Metastatic Prostate Cancer Treatment Market Restraints

Table 15. Global Metastatic Prostate Cancer Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Metastatic Prostate Cancer Treatment Market Share by Players (2020-2025)

Table 17. Global Top Metastatic Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastatic Prostate Cancer Treatment as of 2024)

Table 18. Ranking of Global Top Metastatic Prostate Cancer Treatment Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Metastatic Prostate Cancer Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Metastatic Prostate Cancer Treatment, Headquarters and Area Served

Table 21. Global Key Players of Metastatic Prostate Cancer Treatment, Product and Application

Table 22. Global Key Players of Metastatic Prostate Cancer Treatment, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Metastatic Prostate Cancer Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Type (2020-2025)

Table 26. Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Type (2026-2031)

Table 28. Global Metastatic Prostate Cancer Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Application (2020-2025)

Table 30. Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Application (2026-2031)

Table 32. North America Metastatic Prostate Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Metastatic Prostate Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Metastatic Prostate Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Metastatic Prostate Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Metastatic Prostate Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Metastatic Prostate Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Metastatic Prostate Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Metastatic Prostate Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Metastatic Prostate Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 47. AB Science Company Details

Table 48. AB Science Business Overview

Table 49. AB Science Metastatic Prostate Cancer Treatment Product

Table 50. AB Science Revenue in Metastatic Prostate Cancer Treatment Business (2020-2025) & (US$ Million)

Table 51. AB Science Recent Development

Table 52. BeiGene Company Details

Table 53. BeiGene Business Overview

Table 54. BeiGene Metastatic Prostate Cancer Treatment Product

Table 55. BeiGene Revenue in Metastatic Prostate Cancer Treatment Business (2020-2025) & (US$ Million)

Table 56. BeiGene Recent Development

Table 57. eFFECTOR Therapeutics Company Details

Table 58. eFFECTOR Therapeutics Business Overview

Table 59. eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Product

Table 60. eFFECTOR Therapeutics Revenue in Metastatic Prostate Cancer Treatment Business (2020-2025) & (US$ Million)

Table 61. eFFECTOR Therapeutics Recent Development

Table 62. Immunomedics(Gilead Sciences, Inc.) Company Details

Table 63. Immunomedics(Gilead Sciences, Inc.) Business Overview

Table 64. Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Cancer Treatment Product

Table 65. Immunomedics(Gilead Sciences, Inc.) Revenue in Metastatic Prostate Cancer Treatment Business (2020-2025) & (US$ Million)

Table 66. Immunomedics(Gilead Sciences, Inc.) Recent Development

Table 67. Myovant Biosciences Company Details

Table 68. Myovant Biosciences Business Overview

Table 69. Myovant Biosciences Metastatic Prostate Cancer Treatment Product

Table 70. Myovant Biosciences Revenue in Metastatic Prostate Cancer Treatment Business (2020-2025) & (US$ Million)

Table 71. Myovant Biosciences Recent Development

Table 72. SeleXel Company Details

Table 73. SeleXel Business Overview

Table 74. SeleXel Metastatic Prostate Cancer Treatment Product

Table 75. SeleXel Revenue in Metastatic Prostate Cancer Treatment Business (2020-2025) & (US$ Million)

Table 76. SeleXel Recent Development

Table 77. Zenith Epigenetics Ltd. Company Details

Table 78. Zenith Epigenetics Ltd. Business Overview

Table 79. Zenith Epigenetics Ltd. Metastatic Prostate Cancer Treatment Product

Table 80. Zenith Epigenetics Ltd. Revenue in Metastatic Prostate Cancer Treatment Business (2020-2025) & (US$ Million)

Table 81. Zenith Epigenetics Ltd. Recent Development

Table 82. VasGene Therapeutics, Inc. Company Details

Table 83. VasGene Therapeutics, Inc. Business Overview

Table 84. VasGene Therapeutics, Inc. Metastatic Prostate Cancer Treatment Product

Table 85. VasGene Therapeutics, Inc. Revenue in Metastatic Prostate Cancer Treatment Business (2020-2025) & (US$ Million)

Table 86. VasGene Therapeutics, Inc. Recent Development

Table 87. Telix Pharmaceuticals Company Details

Table 88. Telix Pharmaceuticals Business Overview

Table 89. Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Product

Table 90. Telix Pharmaceuticals Revenue in Metastatic Prostate Cancer Treatment Business (2020-2025) & (US$ Million)

Table 91. Telix Pharmaceuticals Recent Development

Table 92. Arvinas Inc. Company Details

Table 93. Arvinas Inc. Business Overview

Table 94. Arvinas Inc. Metastatic Prostate Cancer Treatment Product

Table 95. Arvinas Inc. Revenue in Metastatic Prostate Cancer Treatment Business (2020-2025) & (US$ Million)

Table 96. Arvinas Inc. Recent Development

Table 97. Amgen Company Details

Table 98. Amgen Business Overview

Table 99. Amgen Metastatic Prostate Cancer Treatment Product

Table 100. Amgen Revenue in Metastatic Prostate Cancer Treatment Business (2020-2025) & (US$ Million)

Table 101. Amgen Recent Development

Table 102. Genentech Company Details

Table 103. Genentech Business Overview

Table 104. Genentech Metastatic Prostate Cancer Treatment Product

Table 105. Genentech Revenue in Metastatic Prostate Cancer Treatment Business (2020-2025) & (US$ Million)

Table 106. Genentech Recent Development

Table 107. Research Programs/Design for This Report

Table 108. Key Data Information from Secondary Sources

Table 109. Key Data Information from Primary Sources

Table 110. Authors List of This Report

List of Figures

Figure 1. Metastatic Prostate Cancer Treatment Picture

Figure 2. Global Metastatic Prostate Cancer Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Metastatic Prostate Cancer Treatment Market Share by Type: 2024 VS 2031

Figure 4. Mono Features

Figure 5. Combination Features

Figure 6. Mono/Combination Features

Figure 7. Global Metastatic Prostate Cancer Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Metastatic Prostate Cancer Treatment Market Share by Application: 2024 VS 2031

Figure 9. Hospital Case Studies

Figure 10. Drug Store Case Studies

Figure 11. Online Pharmacy Case Studies

Figure 12. Metastatic Prostate Cancer Treatment Report Years Considered

Figure 13. Global Metastatic Prostate Cancer Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Metastatic Prostate Cancer Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Metastatic Prostate Cancer Treatment Market Share by Region: 2024 VS 2031

Figure 16. Global Metastatic Prostate Cancer Treatment Market Share by Players in 2024

Figure 17. Global Top Metastatic Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastatic Prostate Cancer Treatment as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Metastatic Prostate Cancer Treatment Revenue in 2024

Figure 19. North America Metastatic Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Metastatic Prostate Cancer Treatment Market Share by Country (2020-2031)

Figure 21. United States Metastatic Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Metastatic Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Metastatic Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Metastatic Prostate Cancer Treatment Market Share by Country (2020-2031)

Figure 25. Germany Metastatic Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Metastatic Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Metastatic Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Metastatic Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Metastatic Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Metastatic Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Metastatic Prostate Cancer Treatment Market Share by Region (2020-2031)

Figure 33. China Metastatic Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Metastatic Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Metastatic Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Metastatic Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Metastatic Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Metastatic Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Metastatic Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Metastatic Prostate Cancer Treatment Market Share by Country (2020-2031)

Figure 41. Mexico Metastatic Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Metastatic Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Metastatic Prostate Cancer Treatment Market Share by Country (2020-2031)

Figure 45. Turkey Metastatic Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Metastatic Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Metastatic Prostate Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. AB Science Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2020-2025)

Figure 49. BeiGene Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2020-2025)

Figure 50. eFFECTOR Therapeutics Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2020-2025)

Figure 51. Immunomedics(Gilead Sciences, Inc.) Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2020-2025)

Figure 52. Myovant Biosciences Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2020-2025)

Figure 53. SeleXel Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2020-2025)

Figure 54. Zenith Epigenetics Ltd. Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2020-2025)

Figure 55. VasGene Therapeutics, Inc. Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2020-2025)

Figure 56. Telix Pharmaceuticals Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2020-2025)

Figure 57. Arvinas Inc. Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2020-2025)

Figure 58. Amgen Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2020-2025)

Figure 59. Genentech Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Metastatic Colorectal Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Metastatic Pancreatic Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Brain Metastasis Therapeutic Market Research Report 2024

Global Castration Resistant Prostate Cancer Treatment Market Research Report 2024

Global Metastatic Bones Cancer Medication Treatment Market Insights Forecast to 2030

Global Metastatic Cancer Treat Drug Market Research Report 2025

Global Medication Treatment of Metastatic Bone Disease Market Insights Forecast to 2030

Global Metastatic Bone Disease Market Insights Forecast to 2030

Global Pancreatic Cancer Metastasis Treatment Market Research Report 2025

Global Metastatic Bones Cancer Market Insights Forecast to 2030

Global Prostate Cancer Diagnosis and Therapy Market Research Report 2024

Global Oncology and Cancer Treatment Drug Market Research Report 2024

Prostate Cancer Minimally Invasive Surgery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Metastatic Lung Adenocarcinoma Treatment Market Research Report 2024

Global Metastases Spinal Tumor Surgery Market Research Report 2025

Metastatic Melanoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Urological Cancer Drugs Market Research Report 2024

Castrate resistant Prostate Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Testicular Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions